Navigation Links
Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status
Date:3/10/2009

Endo Pharmaceuticals, Inc. to terminate the license agreement with all rights to AZ-003 reverting back to Alexza. Alexza and Endo entered into this license agreement in December 2007. The Company does not expect to pursue the development of AZ-003 without a partner.
  • AZ-002 (Staccato alprazolam). Alexza is developing AZ-002 for the acute treatment of panic attacks associated with panic disorder. AZ-002 has completed Phase 1 testing and one Phase 2a proof-of-concept study in panic attacks, an indication the Company is not planning to pursue. However, given the demonstrated safety profile, the successful and reproducible delivery of alprazolam, and the IV-like pharmacological effect demonstrated to date, Alexza and Symphony Allegro are assessing AZ-002 for other possible indications and renewed clinical development.
  • AZ-002 has been licensed to Symphony Allegro, and the Company has the right to repurchase all rights to this product candidate.

    Conference Call Information

    Alexza will host a conference call today, March 10, 2009, at 4:30 p.m. Eastern Time. A replay of the call will be available for two weeks following the event. The conference call, replay and webcast are open to all interested parties.

    To access the conference call via the Internet, go to www.alexza.com, under the "Investor Relations" link. Please join the call at least 15 minutes prior to the start of the call to ensure time for any software downloads that may be required. Interested parties may also pre-register to avoid pre-call delays at

    https://www.theconferencingservice.com/prereg/key.process?key=P9J9NFRUU.

    To access the live conference call via phone, dial 888-713-4213. International callers may acc
    '/>"/>

    SOURCE Alexza Pharmaceuticals, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine news :

    1. Alexzas Corporate Presentation to be Webcast at the Cowen & Company 29th Annual Health Care Conference
    2. Alexza to Announce 2008 Financial Results and Update Its Clinical Pipeline on Tuesday, March 10, 2009
    3. Alexza Pharmaceuticals Promotes Peter D. Noymer, PhD to Vice President, Product R&D
    4. Alexza Pharmaceuticals Announces Upcoming Conference Participation and Webcasts
    5. Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates
    6. Alexza to Announce 2008 Third Quarter Financial Results and Update Its Clinical Pipeline on Thursday, November 6, 2008
    7. Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations
    8. Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd.
    9. Carlos A. Parra Joins Alexza Pharmaceuticals as Vice President, Quality
    10. Alexzas Corporate Presentation to be Webcast at the Seventh Annual JMP Securities Research Conference and the 2008 Citi Investment Research Global Healthcare Conference
    11. Alexza to Webcast Investor and Analyst Day Presentations
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/1/2015)... March 02, 2015 As residents ... works co-founders, Michael Burns and Carita Weaver, believe ... to working with the Southlake Chamber of Commerce, ... web works recently launched a website for Southlake ... A primary communications tool for Hill’s campaign, the ...
    (Date:3/1/2015)... (PRWEB) March 01, 2015 Adults who ... insurance rates for term or universal policies can now ... of the best life insurance companies for single adults ... system at http://quotespros.com/life-insurance.html . , The rate plans ... portal are tied to a number of life protection ...
    (Date:3/1/2015)... 2015 The number of transvaginal mesh ... past few weeks in two New Jersey litigations where ... the Firm announces. , A Case List updated ... Bergen County proceeding established for products manufactured by Johnson ... weeks earlier, when 90 fewer cases had been centralized. ...
    (Date:3/1/2015)... March 01, 2015 Theme and plugin ... transition pack for Final Cut Pro X ... style transitions to any FCPX editors project.” Said Christiana ... users the tools needed to easily drag and drop ... user gets many different controls over the parameters of ...
    (Date:2/28/2015)... TX (PRWEB) March 01, 2015 Heart ... estimated that 10 percent of urban adult population and ... form of heart diseases and 20-30 percent of them ... to heart ailments and coronary vascular diseases (CVD). , ... launched a new market research report titled “Indian Coronary ...
    Breaking Medicine News(10 mins):Health News:Website Launched for Southlake, Texas Mayoral Candidate Laura Hill 2Health News:Best Life Insurance Companies for Single Adults Now Searchable at Insurance Website 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 3Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 4Health News:Announcing a New Transition Pack from Pixel Film Studios, Transccordion for Final Cut Pro X 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 3
    ... drug cocktail might be the right mix to fight ... Details of a new study supporting this approach suggest ... work again. The findings were presented today at the ... involves post-menopausal women whose advanced breast cancers are fueled ...
    ... STATION A gene commonly studied by cancer researchers has been ... Understanding how the gene works means scientists may ... to a study by Texas AgriLife Research appearing in the ... we understand the mechanism, or how the gene works, we believe ...
    ... new vaccines, safety monitoring and improved federal coordination ... and better coordination are needed to develop vaccines for ... new U.S. report says. , The report, from the ... Vaccine Plan. It cites a need to speed up ...
    ... GAINESVILLE, Fla., Dec. 11 For more than 400 ... salamanders, trying to understand how these creatures routinely repair ... paralyzed -- or worse. , Now, fueled by a ... of $2.4 million, a multi-institutional team of researchers associated ...
    ... The controversy over Sen. Harry Reid,s (D-Nev.) request ... purportedly to attend a fundraiser in New Orleans exemplifies ... watchdogs said today. The groups criticized the money-driven political ... time fundraising when they should be addressing the critical ...
    ... DALLAS, Dec. 11 For their unique Return to ... more active cardiac patients, the Cardiac Rehabilitation program at ... Hospital was recently awarded the Innovation Award from the ... award acknowledges programs that have enhanced their delivery of ...
    Cached Medicine News:Health News:Clinical trial advances new approach to re-sensitizing breast cancer 2Health News:Study shows how gene action may lead to diabetes prevention, cure 2Health News:Better Vaccine Planning Needed, Committee Finds 2Health News:Better Vaccine Planning Needed, Committee Finds 3Health News:Effort to Regenerate Injured Spinal Cords Turns to a New Model 2Health News:Effort to Regenerate Injured Spinal Cords Turns to a New Model 3Health News:Effort to Regenerate Injured Spinal Cords Turns to a New Model 4Health News:Controversy Over Reid Fundraiser Exemplifies Need for Fair Elections 2Health News:Baylor Hamilton Heart Hospital Honored for Innovative Rehabilitation Program 2Health News:Baylor Hamilton Heart Hospital Honored for Innovative Rehabilitation Program 3
    (Date:3/1/2015)... , March 1, 2015  Patients suffering from ... against this debilitating foot ailment, according to research ... ,s Annual Scientific Meeting . Researchers utilized ... emulsify and remove diseased fasciitis tissue. Permanently removing ... to regrow in its place, restoring normal function. ...
    (Date:2/27/2015)... 27, 2015 Pharmaceutical and biotech marketers are ... for the same indication. This can be a complex ... prevent one of their brands from gaining market share ... recent research by benchmarking firm, Best Practices, LLC, 75% ... rather than together as part of a franchise. Marketers ...
    (Date:2/27/2015)... NEW YORK , Feb. 27, 2015  Pomerantz ... Vitae Pharmaceuticals, Inc. ("Vitae" or the "Company") (NASDAQ: ... Robert S. Willoughby at rswilloughby@pomlaw.com ... whether Vitae and certain of its officers and/or directors ... Exchange Act of 1934.  On February ...
    Breaking Medicine Technology:Interventional radiology treatment relieves chronic plantar fasciitis 2Interventional radiology treatment relieves chronic plantar fasciitis 3New Report Details How to Expand a Pharmaceutical Product Portfolio without Cannibalizing an Established Brand 2SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vitae Pharmaceuticals, Inc. - VTAE 2
    ... ,, HARBIN, China , July ... the "Company"), a,developer, manufacturer and distributor of botanical products,bio-pharmaceuticals and traditional ... common stock on the NYSE Amex. , ... Renhuang expects to ...
    ... 1 Hanger Orthopedic Group, Inc. was recently ... the January 12th earthquake in Haiti ... development and humanitarian nongovernmental organizations.  Presented with InterAction,s Corporate ... by Physicians for Peace, an InterAction member organization and ...
    Cached Medicine Technology:Renhuang Pharmaceuticals Receives Approval to List on the NYSE Amex 2Renhuang Pharmaceuticals Receives Approval to List on the NYSE Amex 3Hanger Orthopedic Group Honored for its Charitable Relief Efforts in Haiti by InterAction 2Hanger Orthopedic Group Honored for its Charitable Relief Efforts in Haiti by InterAction 3
    Our high quality therapeutic drug monitoring reagents, calibrators and controls are available for most chemistry analyzers. Reproducible and accurate results for your laboratory needs....
    The Emit 2000 Digoxin Assay is a homogeneous enzyme immunoassay intended for use in the quantitative analysis of digoxin in human serum or plasma. Emit 2000 assays are designed for use with most chem...
    The Emit 2000 Digoxin Calibrators are intended for use with the Emit 2000 Digoxin Assay....
    ... At Akers, our ultimate goal is ... early detection and immediate treatment. Each year ... suffer and die from late detection or ... lives and cripple nations., ,By developing, manufacturing ...
    Medicine Products: